Relapsed or Refractory Solid Tumors
1 competing product in clinical development for Relapsed or Refractory Solid Tumors.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib | Eisai | Phase 2 | Completed | 35 |
1 competing product in clinical development for Relapsed or Refractory Solid Tumors.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib | Eisai | Phase 2 | Completed | 35 |